NFG
AQST icon

Next Financial Group’s Aquestive Therapeutics AQST Stock Holding History

Next Financial Group’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1K Hold
200
– – ﹤0.01% 2693
2021
Q3 		$1K Hold
200
– – ﹤0.01% 2567
2021
Q2 		$1K Hold
200
– – ﹤0.01% 2483
2021
Q1 		$1K Hold
200
– – ﹤0.01% 2369
2020
Q4 		$1K Hold
200
– – ﹤0.01% 2247
2020
Q3 		$1K Buy
+200
New +$1.31K ﹤0.01% 2082

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LI
Latash Investments Anchorage, Alaska $129M AUM 14.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Next Financial Group's AQST Position: Q4 2021 in Review

Next Financial Group held its Aquestive Therapeutics (AQST) position steady in Q4 2021 at 200 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2693.

Next Financial Group first reported a position in AQST in Q3 2020 and has held it in 6 quarters since. 52 funds tracked by Wall St. Rank hold AQST as of Q4 2021.

  • Next Financial Group held 200 shares of Aquestive Therapeutics worth $1K as of Q4 2021.
  • Next Financial Group left its Aquestive Therapeutics share count unchanged in Q4 2021.
  • Aquestive Therapeutics made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2693 holding.
  • Next Financial Group first reported a position in Aquestive Therapeutics in Q3 2020 and has held it in 6 quarters since.
  • 52 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.